SERINC5 potently restricts retrovirus infection <i>in vivo</i>
Uddhav Timilsina(University at Buffalo, State University of New York), Spyridon Stavrou(University of Pennsylvania)
Cited by 0
Related Papers
SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5
|Nature Communications|2022|66
Different Modes of Retrovirus Restriction by Human APOBEC3A and APOBEC3G In Vivo
|PLoS Pathogens|2014|61
MARCH2, a T cell specific factor that restricts HIV-1 infection
|PLoS Pathogens|2024|6
Elucidating the antiviral mechanism of different MARCH factors
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2
SARS-CoV-2 ORF7a Mutation Found in BF.5 and BF.7 Sublineages Impacts Its Functions
|International Journal of Molecular Sciences|2024|2